Archive for News
February 13, 2012 at 9:35 pm · Filed under News, pain, Diet and Fitness, Arthritis, Health
(Best Syndication News) - Exercise as a young adult to reduce the risk for fractures caused by osteoporosis later on in life, concluded a study conducted in Sweden.
The University of Gothenburg’s Sahlgrenska Academy researchers studied 833 Swedish men to determine that exercise in the early twenties helped to promote bone growth. Previous research concluded that the more bone mass people accumulate when young, the lower the risk for fractures from osteoporosis when they are older. In addition, other research has found that exercise before and during puberty is beneficial in making bones stronger.
read more
Original post by Marsha Quinn
December 23, 2011 at 11:36 am · Filed under News, Recall, pain, Rheumatoid Arthritis, Health, Arthritis, Fibromyalgia
(Best Syndication News) - The US Food and Drug Administration announced that The McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. is voluntarily recalling certain lots of Motrin products because the company is concerned that they might not dissolve as quickly when they near the expiration date. They determined this during sample product testing and will recall the product from retailers only for quality standard concerns.
There are no adverse events or health risks with this recall. The medicine can still be taken; however, the company wants to let consumers know that the product can be delayed in offering pain relief when nearing the expiration date. The company will be recalling the product from retailers of the involved lots. They will not be issuing a consumer product recall at this time. The products were distributed to the US, Puerto Rico, Bahamas, Fiji, Belize, ST. Lucia, and Jamaica.
read more
Original post by Marsha Quinn
April 19, 2011 at 4:16 pm · Filed under News, Rheumatoid Arthritis, Arthritis, Health
|
|
Best Syndication News
|
|
(Best Syndication News) - Two rare disorders that cause vasculitis, Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), have a new treatment called Rituxan (rituximab) that was approved by the FDA today. The Rituxan along with glucocorticoids (steroids) is the treatment that was approved for the treatment of these rare disorders. Rituxan is the first approved therapy that is used to treat these diseases. Rituxan is made by Genentech, who is part of the Roche Group. Rituxan has been approved since 1997 to treat non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.
Rituxan uses biotechnology methods to make an antibody that reduces the amount ‘B cells’ which are specific immune cells. There was a single controlled trial study of 197 patients that had either WG or MPA. The researchers randomly assigned the patient Rituxan plus glucocorticoids once a week for four weeks or they gave the patient an oral cyclophosphamide plus glucocorticoids daily. The study duration at six months showed the patients that had the Rituxan with the glucocorticoids had 64 percent of the patients have complete remission. The cyclosphosphamide and glucocorticoids patients had 53 percent achieve complete remission.
read more
Original post by Nicole Wilson
March 30, 2011 at 11:45 am · Filed under News, pain, Arthritis, Health
|
|
Tylenol 8 hour extended release recalled
|
|
(Best Syndication News) - The Mcneil Consumer Healthcare announced the voluntary recall of over-the-counter Tylenol 8 Hour Extended Release Caplets 150 count bottles because of a musty or moldy odor. The smell comes from tiny amounts of 2,4,6-tribromoanisole (TBA) and 2,4,6-trichloroanisole (TCA). The risk for any adverse medical events is rare. The recalled Tylenol product was manufactured in Fort Washington, Pennsylvania and distributed in the United States.
The recalled Tylenol will have the following lot numbers and UPC codes which are located on the side of the bottle’s label. The UPC code is 300450297181 and the only lot number involved is ADM074.
read more
Original post by Nicole Wilson
